Biocor Instituto, Nova Lima, Brazil; and Hospital Cardiólogico, Florianopolis, Santa Catarina, Brazil), with accessory atrioventricular pathways (AP) refractory to multiple endocardial attempts of catheter ablation between 2001 and 2013. All patients referred to our centers underwent a simultaneous endocardial and epicardial approach. The flowchart of the clinical-electrophysiological decision-making process is depicted in Figure 1 .
Methods

Anatomic Evaluation
Coronary sinus anatomy was assessed in 16 patients by venous angiography, with multislice computer tomography in 3 patients. Cases 1 and 21 underwent MRI to assess right atrium anatomy (Table 1 and Figures 2 and 3 ).
Pericardial Puncture
The technique was reported elsewhere. 15 In 19 patients, a conventional 7F sheath was introduced in the pericardial space. In two (#10 and #11), an 8.5F introducer was used with a steerable pericardial sheath (Agilis, S Jude Medical, Minneapolis, MN). Coronary angiography was performed to check proximity of the ablation site with coronary arteries (we considered safe a minimum distance of 5 mm). 5 A 5F pigtail catheter was used to drain the accumulated pericardial fluid in case of open irrigated-tip catheter ablation. All catheters and sheaths were removed at the end of the procedure.
Electrophysiological Study, Mapping, and Catheter Ablation
Electrophysiological study was performed with the EP Tracer System (Cardiotek BV, Maastricht, The Netherlands). In general, patients with posteroseptal and left-sided APs underwent left atrial instrumentation through transeptal puncture (13 patients) , and in 2 patients, a retrograde transaortic access was also used ( Table 2) . Percutaneous subxiphoid pericardial access was successfully performed in all patients. Assessment of the ablation target was based on early ventricular activation mapping during sinus or atrial pacing and on earliest atrial activation site during atrioventricular re-entrant tachycardia or ventricular pacing. Catheter ablation with an endocardial approach (including ablation inside the middle cardiac vein and coronary sinus) was performed with 4-or 8-mm ablation catheters except in 3 patients where an open irrigated-tip catheter (Thermocool, Biosense Webster, Diamond Bar, CA) was used ( Table 2) . A Stockert radiofrequency ablation generator (Biosense Webster, Johnson & Johnson) was used in all cases. Coronary angiography was performed to check proximity to a major coronary artery branch before ablation.
Surgery
Open-chest heart surgery with cardiopulmonary bypass and cryoablation 16 was performed in patients with high-risk Wolff-Parkinson-White syndrome-related arrhythmias after undergoing a failed endocardial-epicardial approach. In those patients with coronary sinus diverticulum, surgery consisted of diverticulum resection and cryoablation application with a probe to the diverticulum neck.
Follow-Up
Patients underwent a transthoracic echocardiogram in the day after the procedure. Each patient returned in the outpatient clinic at least once before 3 months after the procedure. After that evaluation, the patient was referred back to the referring physician for long-term follow-up. The median follow-up was 30 months (range, 1-133 months).
Statistical Analysis
All variables are presented as median and range.
Results
Patient Characteristics
Twenty-one patients were included in the study. They had undergone a median of 2 previous ablation procedures (range, 0-4). The median age was 29 years old (range, 18-66), and 14 patients were males (66.7%). Eight of the 21 patients (38%) had atrial fibrillation with fast ventricular rate, and 3 (14%) had Figure 1 . Flowchart of the management and outcomes of catheter ablation in 21 patients with Wolff-Parkinson-White syndrome (WPW) who underwent endocardial/epicardial mapping and ablation. CS indicates coronary sinus; ENDO < EPI, endocardial activation mapping earlier than epicardial; EPI < ENDO, epicardial activation mapping earlier than endocardial; EPI=ENDO, isochronic endocardial and epicardial activation mapping; MCV, middle cardiac vein; and RF, radiofrequency.
WHAT IS KNOWN
• Epicardial accessory pathways can often be ablated from a coronary venous approach but requires proximity of the vein to the pathway.
• Use of a percutaneous subxiphoid approach to the pericardial space for ablation has been shown to be feasible in largely anecdotal reports.
WHAT THE STUDY ADDS
• A percutaneous subxiphoid approach achieved successful ablation in 6 of 21 patients referred for a suspected epicardial accessory pathway after previous failed ablation attempts.
• Repeat endocardial or epicardial transvenous approaches informed by epicardial mapping were successful in a third of patients when the subxiphoid approach failed.
• Open-chest surgery was necessary for ablation in a cardiac arrest as the presenting arrhythmia (patient 11 was in coma for 10 days and underwent hemodialysis for 15 days.). Seventeen patients (81%) had atrioventricular re-entrant tachycardia as their clinical arrhythmia (4 patients had a history of atrioventricular re-entrant tachycardia and atrial fibrillation).
Mapping and Ablation Results
Epicardial mapping and ablation were successful in 6 patients (28.5%), whereas in 7 patients (33%), a subsequent endocardial or epicardial transvenous mapping and ablation resulted in AP elimination. In 4 patients (19%), open-chest surgery was necessary for the elimination of the AP. The other 4 patients (19%) had a failed endocardial and epicardial ablation (Tables 1 and 2).
AP Localization
The most common AP position was posteroseptal in 12 patients (57%), left free wall and left posterior in 4 (19%), right posterior or right lateral in 3 (14.2%), and anteroseptal in 2 (9.5%). Two right-lateral APs (66.7%), 3 posteroseptal (25%), and 1 left lateral (25%) were successfully ablated through percutaneous epicardial approach, whereas no anteroseptal pathway was epicardially ablated (P = non-significant).
Anatomic Evaluation
Case 21 had a right atrium appendage-right ventricle diverticulum with thrombi diagnosed by MRI. Three patients were diagnosed with acquired postablation coronary sinus stenosis ranging from mild (case 4) to moderate (cases 5 and 15).
Pericardial Instrumentation Access and Complications
Pericardial access via percutaneous subxiphoid puncture was accomplished in all patients. One patient (case 3) had hemopericardium diagnosed immediately after introduction of the dilator. In this patient, after draining 100 mL of blood, bleeding stopped and procedure resumed without any further bleeding. Case 19 developed acute pericarditis, which resolved with a nonsteroid anti-inflammatory drug. There were no other complications related to the catheter ablation procedure. following categories: (1) Epicardial activation earlier than endocardial approach activation. All 6 patients with earliest epicardial activation underwent successful ablation from the epicardium. A likely AP potential was seen at the earliest activation site in 4 of the 6 patients (Table 1 and Figures 3 and  4 as well as Figure I in the Data Supplement); (2) Simultaneous early activation at the epicardium and endocardium close to the mitral annulus was seen in 3 patients, and 2 patients were successfully ablated from the endocardium approach, guided by epicardial mapping; and (3) Endocardial approach activation was earlier than epicardial (9 patients), the earliest activation in those 9 patients was found in the middle cardiac vein (3 patients), coronary sinus (2 patients), an endocardial site at the tricuspid annulus (3 patients), and at the mitral annulus (1 patient). Ablation of the AP was successful in 2 of the 3 patients in the middle cardiac vein. Both patients with earliest activation at the coronary sinus failed catheter ablation. Those 2 patients had acquired moderate coronary sinus stenosis from previous ablation attempts. In all 9 patients who underwent radiofrequency ablation attempts, the ablation sites were assessed with a coronary angiography and deemed safe (distance greater than 5 mm).
Endocardial-Epicardial Mapping and Ablation
Procedure Time
The median total procedure time in this series was 200 minutes (ranged from 110 to 375 minutes).
Surgery
Four patients underwent open-chest heart surgery with cardiopulmonary bypass and cryoablation ( Table 2 ). Patient 16 had a giant coronary sinus diverticulum with multiple dilated epicardial vessels and coronary sinus ostium atresia. Resection of the diverticulum as well as reconstruction of the coronary sinus ostium and course was necessary in this patient ( Figures 5 and 6 ).
Follow-Up
None of the 17 patients who underwent successful catheter or surgical ablation had recurrence of AP conduction or symptoms. Two patients (cases 3 and 20) are under antiarrhythmic drug therapy and are asymptomatic, while 1 patient was referred for open irrigated-tip catheter ablation (case 17), and case 20 was lost to follow-up.
Discussion
The major findings of this study are as follows: 1) percutaneous epicardial approach can be an alternative when endocardial or transvenous AP ablation fails; however, in this series, this approach was successful in only 6 patients (28.5%) and 2) additional endocardial or transvenous epicardial mapping was successful in 7 patients (33%).
Four scenarios were identified: 1) the presence of a true epicardial AP identified by an earliest activation site at the epicardium and subsequent ablation of the AP; 2) the identification of an early epicardial activation site as a reference for successful endocardial ablation; 3) absence of an epicardial site showing early activation, and successful ablation with further endocardial mapping; and 4) no epicardial or endocardial site with early activation to allow successful ablation was found. The scenarios 2, 3, and 4 could be explained by the epicardial fat that usually is thick and close to the AV annulus precluding accessory-pathway mapping and elimination.
Successful Ablation From Percutaneous Epicardial Instrumentation
Six patients were successfully ablated from a pericardial site. In 2 patients (cases 10 and 11), maneuverability, stability, and contact force of the catheter with the tissue were much improved using a steerable sheath (Figures 2 and 3 ). Both patients had an epicardial posteroseptal AP. An irrigated-tip catheter was used in 4 of 6 patients successfully ablated from the epicardium and probably played a role. Schweikert et al 10 reported epicardial mapping in a cohort of 10 patients with refractory APs. Only 3 patients (30%) that presented a right atrial appendage-right ventricle diverticulum could be ablated from the epicardium, and no other AP location had early activation or successful ablation from the epicardium. 10 We also had 1 patient with right atrial appendage-right ventricle diverticulum ablated from the epicardium. However, other locations such as posteroseptal, left posterior, and right posterior could also be ablated from the epicardium, expanding the prospect of ablation to more patients with an AP not amenable to endocardial approach ablation. Valderrabano et al 11 reported epicardial ablation in 2 of 6 patients (33%), one in the right free-wall and the other in the right posteroseptal region. In some patients with diverticulum (coronary sinus or right atrial appendage-right ventricle), with a more extensive area of contact between atrium and ventricle, multiple endocardial and epicardial radiofrequency applications might be needed to achieve a complete ablation. 17 The successful ablation site, however, would be considered epicardial if the last application was delivered from that site, but contribution from endocardial applications to the final result must be acknowledged in such an instance. This happened in case 21 who received multiple endocardial and epicardial radiofrequency applications, but the epicardial site was considered the site of successful ablation.
Anatomic Reason for Failure of Percutaneous Epicardial Ablation
The success of percutaneous epicardial ablation in the present series (28.5%) was similar to that of previous reports by Schweikert et al 10 and Valderrabano et al, 11 which were 30% and 33%, respectively. The likely explanation for this limited success rate may be related to the anatomy of the AV groove. Becker et al 8 examined the heart of patients with APs showing that they are epicardial structures. There is a thick epicardial fat layer covering the region where APs sit, which is significant enough to be a limitation to a better performance of the percutaneous epicardial approach in most patients. Another structure that could limit the AP elimination is the coronary artery because myocardial tissue and the AP that are located underneath large epicardial arteries frequently remained intact after ablation. 18
Epicardial Mapping Guiding Endocardial Ablation
The concept that epicardial mapping may enhance the effectiveness of endocardial ablation was introduced during ventricular tachycardia ablation. 19 The role of epicardial mapping in guiding endocardial catheter ablation was previously reported. 10, 11 In our series, only 3 patients had similar activation times from endocardium and epicardium. Successful endocardial ablation was achieved in two. In Scheikert et al series, 10 
Successful Endocardial Ablation Unrelated to Epicardial Mapping
Five of 8 patients were successfully ablated from the endocardium approach after they underwent a second round of endocardial mapping (endocardium and coronary venous system when appropriate) after epicardial mapping. Our results in those 5 patients indicate that it is not always correct to equal failure of epicardial mapping in finding an adequate early site of activation with indication for surgery, as suggested by Valderrabano et al. 11 We cannot explain why the adequate site of ablation was not found during the initial endocardial mapping. However, after a thorough pericardial mapping without finding an adequate target, the operator was provided with critical information, which was not present before, that the endocardial approach would be the only one standing a chance of success. As a result, more emphasis and stamina were put forward in finding the spot from the endocardium.
Failure of Catheter Ablation of an AP in Highly Symptomatic Patients
A critical decision has to be made when catheter ablation is not possible. Patients referred for open-chest surgery usually underwent multiple procedures at different centers. In our series, a median of 3 procedures were performed before the percutaneous epicardial approach in the patients that underwent surgery (vs 1 without surgery). We want to stress that it is crucial to repeat endocardium mapping after making sure that no early activation was found under the subxyphoid epicardial approach. This made the difference in 24% of our patients.
Another important issue is the use of irrigated-tip technology. Irrigated-tip ablation catheter was used in only 7 patients (Table 2) , and a successful ablation was achieved in 4 patients. On the other hand, 14 patients underwent catheter ablation with regular 4-or 8-mm tip catheter, and successful ablation was attained in 9 patients. The use of irrigated-tip ablation catheters could have improved results, particularly in patients with an AP located in the coronary sinus venous system, like patients 17 and 18, who had an AP mapped inside the middle cardiac vein (case 17 had transient disappearance of preexcitation during radiofrequency application). Unfortunately, we did not have the irrigated-tip technology available in all patients because some procedures were performed before this technology was available. This important issue needs to be prospectively addressed.
The presence of an associated anatomic abnormality is not a priori an impediment to a successful catheter ablation procedure. Successful ablation was accomplished in 1 of the 2 patients with a coronary sinus diverticulum and in the only patient with a right atrium-right ventricle diverticulum. However, coronary sinus stenosis caused by radiofrequency applications inside the coronary sinus in previous procedures probably played a role in not achieving success in the 2 patients that presented moderate stenosis, in one of whom open-chest surgery was necessary. Patient 16, with a giant coronary sinus diverticulum and ostium atresia ( Figures 5 and 6) , is an example of the limitation of the technique: an impossible 
Procedure Time
Electroanatomic mapping was not usually performed during AP ablation procedures. In our series, only 1 patient underwent electroanatomic mapping (case 12). However, given the long-lasting procedure times, the use of nonfluoroscopic imaging technique to limit radiation exposure is advisable.
Acquired Postablation Decremental Conduction
Two patients (cases 11 and 21; Table 1 ) showed a change in their AP electrophysiological characteristics, which acquired slow conduction and decremental properties while losing ventriculoatrial conduction capability. Sternick et al 20 reported a series of patients with postablation decremental properties and found that posteroseptal septal AP located inside the coronary sinus venous system was at greatest risk (odds 1:6) of developing decremental properties. They suggested that in spite of the change in A-V conduction, they were still capable of being part of an arrhythmia circuit; therefore, they should be targeted for ablation. Cases 11 and 21 only had atrial fibrillation. Case 11 developed a Mahaim-like physiology after radiofrequency current was applied in the middle cardiac vein. Atrioventricular conduction time became decremental, but the refractory period was still short and the AP was eventually ablated from the pericardial space ( Figure 2) . Case 21 had a right-lateral AP associated with a right atrium diverticulum, and after 38 applications of radiofrequency pulses, ventricular pre-excitation was only exposed during atrial pacing, ventriculoatrial conduction was abolished, and anterograde refractory period became prolonged, which was considered a valid end point. This patient was asymptomatic in the long-term follow-up, without ventricular pre-excitation at the ECG.
Limitations
This series included patients since 2001, and no irrigated-tip catheters were available in the early cases of this series. One could argue that if this technology were available, it could have precluded the need for an epicardial approach in some patients, particularly those in close proximity with the coronary venous system.
Conclusions
Epicardial ablation through percutaneous subxiphoid access was successful in a minority of patients in whom this approach was attempted. A new attempt of endocardial mapping and transvenous approach is highly advisable after a failed percutaneous epicardial approach. A subset of patients may require open-chest surgery. Pericardial instrumentation was safe in this series of patients. Anatomy evaluation conducted prior to the procedure, use of a steerable sheath, and irrigated-tip catheters may improve patient selection and ablation results.
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